Company: AEMD
Filing Date: 2025-02-12
Form Type: 10-Q
Source: 0001683168-25-000960
Chunk: 2

Company: AETHLON MEDICAL INC
Filing Date: 2025-02-12
Form: 10-Q
Item: Item 1
Chunk 2
---
 (10,150,594)

    OTHER INCOME 

    Interest Income 
     (59,964) 
     (100,967) 
     (204,206) 
     (367,838)

    NET LOSS 
     (1,754,783) 
     (3,466,121) 
     (7,133,196) 
     (9,782,756)

    OTHER COMPREHENSIVE INCOME (LOSS) 
     (13,057) 
     7,951  
     (10,085) 
     4,522 

    COMPREHENSIVE LOSS 
    $(1,767,840) 
    $(3,458,170) 
    $(7,143,281) 
    $(9,778,234)

    Basic and diluted loss per share attributable to common stockholders 
    $(0.13) 
    $(1.37) 
    $(0.61) 
    $(3.95)

    Weighted average number of common shares outstanding – basic and diluted 
     13,962,266  
     2,516,511  
     11,801,655  
     2,477,282 

The accompanying notes are an integral part
of these condensed consolidated financial statements.

 5 

AETHLON MEDICAL, INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’
EQUITY

For the Three and Nine Months Ended December 31,
2024 and 2023

(Unaudited)

    COMMON STOCK  
    ADDITIONAL PAID IN  
    ACCUMULATED COMPREHENSIVE  
    ACCUMULATED  
    TOTAL 

    SHARES  
    AMOUNT  
    CAPITAL  
    INCOME (LOSS)  
    DEFICIT  
    EQUITY 
  
    BALANCE – MARCH 31, 2024 
     2,629,725  
    $2,629  
    $160,337,371  
    $(6,940) 
    $(154,566,728) 
    $5,766,332 
  
    Issuances of common stock for public offering 
     8,100,000  
     8,100  
     3,531,807